Cargando…
Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization
BACKGROUND: Mannosylglycerate (MG) is one of the most widespread compatible solutes among marine microorganisms adapted to hot environments. This ionic solute holds excellent ability to protect proteins against thermal denaturation, hence a large number of biotechnological and clinical applications...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240254/ https://www.ncbi.nlm.nih.gov/pubmed/30445960 http://dx.doi.org/10.1186/s12934-018-1023-7 |
_version_ | 1783371606789193728 |
---|---|
author | Faria, Cristiana Borges, Nuno Rocha, Isabel Santos, Helena |
author_facet | Faria, Cristiana Borges, Nuno Rocha, Isabel Santos, Helena |
author_sort | Faria, Cristiana |
collection | PubMed |
description | BACKGROUND: Mannosylglycerate (MG) is one of the most widespread compatible solutes among marine microorganisms adapted to hot environments. This ionic solute holds excellent ability to protect proteins against thermal denaturation, hence a large number of biotechnological and clinical applications have been put forward. However, the current prohibitive production costs impose severe constraints towards large-scale applications. All known microbial producers synthesize MG from GDP-mannose and 3-phosphoglycerate via a two-step pathway in which mannosyl-3-phosphoglycerate is the intermediate metabolite. In an early work, this pathway was expressed in Saccharomyces cerevisiae with the goal to confirm gene function (Empadinhas et al. in J Bacteriol 186:4075–4084, 2004), but the level of MG accumulation was low. Therefore, in view of the potential biotechnological value of this compound, we decided to invest further effort to convert S. cerevisiae into an efficient cell factory for MG production. RESULTS: To drive MG production, the pathway for the synthesis of GDP-mannose, one of the MG biosynthetic precursors, was overexpressed in S. cerevisiae along with the MG biosynthetic pathway. MG production was evaluated under different cultivation modes, i.e., flask bottle, batch, and continuous mode with different dilution rates. The genes encoding mannose-6-phosphate isomerase (PMI40) and GDP-mannose pyrophosphorylase (PSA1) were introduced into strain MG01, hosting a plasmid encoding the MG biosynthetic machinery. The resulting engineered strain (MG02) showed around a twofold increase in the activity of PMI40 and PSA1 in comparison to the wild-type. In batch mode, strain MG02 accumulated 15.86 mg(MG) g(DCW)(−1), representing a 2.2-fold increase relative to the reference strain (MG01). In continuous culture, at a dilution rate of 0.15 h(−1), there was a 1.5-fold improvement in productivity. CONCLUSION: In the present study, the yield and productivity of MG were increased by overexpression of the GDP-mannose pathway and optimization of the mode of cultivation. A maximum of 15.86 mg(MG) g(DCW)(−1) was achieved in batch cultivation and maximal productivity of 1.79 mg(MG) g(DCW)(−1) h(−1) in continuous mode. Additionally, a positive correlation between MG productivity and growth rate/dilution rate was established, although this correlation is not observed for MG yield. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-018-1023-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6240254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62402542018-11-26 Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization Faria, Cristiana Borges, Nuno Rocha, Isabel Santos, Helena Microb Cell Fact Research BACKGROUND: Mannosylglycerate (MG) is one of the most widespread compatible solutes among marine microorganisms adapted to hot environments. This ionic solute holds excellent ability to protect proteins against thermal denaturation, hence a large number of biotechnological and clinical applications have been put forward. However, the current prohibitive production costs impose severe constraints towards large-scale applications. All known microbial producers synthesize MG from GDP-mannose and 3-phosphoglycerate via a two-step pathway in which mannosyl-3-phosphoglycerate is the intermediate metabolite. In an early work, this pathway was expressed in Saccharomyces cerevisiae with the goal to confirm gene function (Empadinhas et al. in J Bacteriol 186:4075–4084, 2004), but the level of MG accumulation was low. Therefore, in view of the potential biotechnological value of this compound, we decided to invest further effort to convert S. cerevisiae into an efficient cell factory for MG production. RESULTS: To drive MG production, the pathway for the synthesis of GDP-mannose, one of the MG biosynthetic precursors, was overexpressed in S. cerevisiae along with the MG biosynthetic pathway. MG production was evaluated under different cultivation modes, i.e., flask bottle, batch, and continuous mode with different dilution rates. The genes encoding mannose-6-phosphate isomerase (PMI40) and GDP-mannose pyrophosphorylase (PSA1) were introduced into strain MG01, hosting a plasmid encoding the MG biosynthetic machinery. The resulting engineered strain (MG02) showed around a twofold increase in the activity of PMI40 and PSA1 in comparison to the wild-type. In batch mode, strain MG02 accumulated 15.86 mg(MG) g(DCW)(−1), representing a 2.2-fold increase relative to the reference strain (MG01). In continuous culture, at a dilution rate of 0.15 h(−1), there was a 1.5-fold improvement in productivity. CONCLUSION: In the present study, the yield and productivity of MG were increased by overexpression of the GDP-mannose pathway and optimization of the mode of cultivation. A maximum of 15.86 mg(MG) g(DCW)(−1) was achieved in batch cultivation and maximal productivity of 1.79 mg(MG) g(DCW)(−1) h(−1) in continuous mode. Additionally, a positive correlation between MG productivity and growth rate/dilution rate was established, although this correlation is not observed for MG yield. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-018-1023-7) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-16 /pmc/articles/PMC6240254/ /pubmed/30445960 http://dx.doi.org/10.1186/s12934-018-1023-7 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Faria, Cristiana Borges, Nuno Rocha, Isabel Santos, Helena Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization |
title | Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization |
title_full | Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization |
title_fullStr | Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization |
title_full_unstemmed | Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization |
title_short | Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization |
title_sort | production of mannosylglycerate in saccharomyces cerevisiae by metabolic engineering and bioprocess optimization |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240254/ https://www.ncbi.nlm.nih.gov/pubmed/30445960 http://dx.doi.org/10.1186/s12934-018-1023-7 |
work_keys_str_mv | AT fariacristiana productionofmannosylglycerateinsaccharomycescerevisiaebymetabolicengineeringandbioprocessoptimization AT borgesnuno productionofmannosylglycerateinsaccharomycescerevisiaebymetabolicengineeringandbioprocessoptimization AT rochaisabel productionofmannosylglycerateinsaccharomycescerevisiaebymetabolicengineeringandbioprocessoptimization AT santoshelena productionofmannosylglycerateinsaccharomycescerevisiaebymetabolicengineeringandbioprocessoptimization |